Drug Trial Radar · NCT06950385
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Last checked: Nov 19, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
168
Planned (sponsor's estimate)
Start
Jul 18, 2025
Primary completion
Jul 2030
Study completion Jan 2031
Sponsor
- Lead sponsor
- Rapamycin Holdings Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Biodexa Pharmaceuticals
- First posted
- Apr 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main goal of this clinical trial is to learn if the drug eRapa works to slow down the progression of disease in patients diagnosed with Familial Adenomatous Polyposis (FAP). Researchers will compare eRapa to Placebo. The questions to be answered by this trial are: * Does taking eRapa help to slow down the progression of the disease in patients with FAP? * Is eRapa a safe treatment for patients diagnosed with FAP? * What is the effect of eRapa on the number of polyps found in GI tract of patients diagnosed with FAP? * How does treatment with eRapa affect a patient's quality of life? Participants will: * Take eRapa or placebo once per day every other week until disease progresses (gets worse), stops taking part in the trial or dies. * Visit the clinic once every 3 months for check ups and tests. * Have an endoscopy at the start of the trial and then every 6 months to check on whether the disease is getting better or worse.
Conditions
- Familial Adenomatous Polyposis (FAP)
Interventions
eRapa (encapsulated rapamycin)Drug
0.5 mg capsules for oral use; white opaque capsule filled with off-white powder; Trial intervention will be provided in 28-count round high-density polyethylene bottles with a polypropylene child-resistant screw cap and foil induction seal.
PlaceboDrug
Capsules in 28-count round high-density polyethylene bottles with a polypropylene child-resistant screw cap and foil induction seal.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS) in high-risk patients with FAP treated with eRapa versus placebo.Time frame: 3 years
Locations
29 sites in 7 countries. Site status is shown where the registry gives one.
City of Hope
Arcadia, California · Recruiting
Yale Cancer Center
New Haven, Connecticut · Recruiting
Georgetown University
Washington D.C., District of Columbia · Recruiting
Digestive & Liver Center of Florida
Orlando, Florida · Recruiting
Cleveland Clinic Florida
Weston, Florida · Recruiting
University of Chicago
Chicago, Illinois · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
Johns Hopkins University
Baltimore, Maryland · Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts · Recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
Department of Surgery, Section of Colon Rectal and Surgery
St Louis, Missouri · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
Ohio State University
Columbus, Ohio · Recruiting
Geisinger Medical Center
Danville, Pennsylvania · Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania · Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Benaroya Research Institute at Virginia Mason
Seattle, Washington · Recruiting
University of Washington - Fred Hutchinson
Seattle, Washington · Recruiting
Copenhagen University Hospital
Copenhagen, Denmark · Recruiting
Universitätsklinikum Bonn
Bonn, Germany · Recruiting
IRCCS Ospedale San Raffaele
Milan, Italy · Recruiting
Istituto Nazionale dei Tumori
Milan, Italy · Recruiting
Amsterdam UMC
Amsterdam, Netherlands · Recruiting
Radboud University Medical Center
Nijmegen, Netherlands · Recruiting
Hospital Oncologico - Puerto Rico Medical Center
Rio Piedras, Puerto Rico · Recruiting
Hospital Clínic de Barcelona
Barcelona, Spain · Recruiting
Hospital Comarcal de Inca
Inca, Spain · Recruiting
Hospital General Universitario Gregorio Marañón
Madrid, Spain · Recruiting
Hospital La Fe de Valencia
Valencia, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.